BODY Beachbody Company Inc

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-258149

PROSPECTUS SUPPLEMENT NO. 3

(to prospectus dated August 6, 2021)

THE BEACHBODY COMPANY, INC.

This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated August 6, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-258149). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

This prospectus supplement is being filed to update, amend and supplement the information included in the Prospectus with the information contained in our Current Report on Form 8-K filed with the SEC on November 30, 2021, which is set forth below.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

Our shares of Common Stock are listed on The New York Stock Exchange under the symbol “BODY.” On November 29, 2021, the closing sale price per share of our Common Stock was $2.62. Our public warrants are listed on The New York Stock Exchange under the symbol “BODY WS.” On November 29, 2021, the closing sale price per warrant of our public warrants was $0.51.

Investing in our securities involves risks that are described in the “Risk Factors” section beginning on page 11 of the Prospectus.

Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is November 30, 2021.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

November 24, 2021

Date of Report (date of earliest event reported)

Registrant’s telephone number, including area code: (310) 883-9000

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

On November 24, 2021, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Board”) of The Beachbody Company, Inc. (the “Company”), and pursuant to the Amended and Restated Bylaws of the Company, the Board expanded the size of the Board from 6 to 7 directors and appointed Kristin Frank to fill the vacancy created by such expansion. The Company’s Board is declassified. In connection with such Board appointment, effective as of November 24, 2021, Ms. Frank was appointed to the Compensation and Nominating and Corporate Governance Committees Committees of the Board. The Company announced the appointment of Ms. Frank in its November 30, 2021 press release. A copy of that press release is being filed with this Form 8-K as Exhibit 99.1.

Ms. Frank has served as the Chief Executive Officer or President at AdPredictive since September 2018. Prior to AdPredictive, she held multiple leadership positions at Viacom, Inc. (now ViacomCBS Inc.), a public mass media and entertainment conglomerate corporation, having served as the Chief Operating Officer of MTV from 2015 to 2017 and before that serving as the Executive Vice President, Head of Digital in the Music and Entertainment Division, from 2013 to 2015. During her time at Viacom, Ms. Frank also served as the General Manager of MTV & VH1 Digital Media from 2009 to 2012, Chief Operating Officer of LOGO TV from 2005 to 2009 and Regional Vice President of Content Distribution and Marketing from 1995 to 2005. Ms. Frank’s career began in finance working for Heller Financial which was acquired by GE. Ms. Frank is currently a director and the chairman of the Compensation Committee and serves on the Nominating and Governance Committee of Brightcove, Inc. and a board director, a member of the Audit Committee, and the chairman of the Compensation Committee of Gaia, Inc. Formerly, she served as a member of the board of directors at Gaiam, Inc., which was sold to Sequential Brands Group in 2016. Ms. Frank obtained a Bachelor of Business Administration from the University of Iowa.

Pursuant to the Company’s non-employee director compensation program, Ms. Frank was granted on the date of her appointment an initial restricted stock unit award to purchase 42,487 shares of the Company’s common stock, which vest in full on the earlier of (i) the one-year anniversary of the applicable grant date and (ii) the date of the next annual meeting of the Company’s stockholders following the grant date, subject to Ms. Frank’s continued service through the applicable vesting date. Ms. Frank will also be granted an annual restricted stock unit award with a value of $200,000 each calendar year beginning with calendar year 2022. The number of restricted stock units subject to an annual award will be determined by dividing the value by the closing price for the Company’s Class A common stock on the applicable grant date. Each annual award will vest in full on the earlier to occur of (i) the one-year anniversary of the applicable grant date and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Ms. Frank will receive cash compensation for her service on the Board in accordance with the Company’s non-employee director compensation program, as such program may be amended from time to time. Ms. Frank has also entered into the Company’s standard form of Indemnification Agreement.

There is no arrangement or understanding between Ms. Frank and any other person pursuant to which Ms. Frank was appointed as a director. Ms. Frank is not a party to any transaction that would require disclosure under Item 404(a) of Regulation S-K promulgated under the Securities Act of 1933, as amended. The Board has determined that Ms. Frank is an independent director in accordance with the listing requirements of the New York Stock Exchange.